Pro upřesnění je nutné upozornit, že Thymový Protein A je v publikacích nazývaný různě, postupně tak, jak byla rozeznávána jeho úloha v těle a terapeutické možnosti v léčbě lidí nebo zvířat.
Thymic Protein A = Epithyme = Lymphocyte T Cell Immunomodulator LTCI = S Celelergin = TISF …
Journal Of Nutritional & Environmental Medicine
Improved immune activation markers in Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) patients treated with Thymic Protein A
Zlepšení markerů imunitní aktivace u pacientů se syndromem chronické únavy a imunitní dysfunkce (CFIDS) léčených brzlíkovým proteinem A.
Life Extension Report – Anti-Aging
Thymic Protein A: Its Development May Signal a New Tool for Rejuvenating Immune Function
Thymic Protein A: jeho výzkum může představovat nový způsob pro obnovení imunitních funkcí
Zvýšení množství Th lymfocytů
Nutrition Science News
Thymic Protein A May Enhance Immunity
Townsend Letter For Doctors & Patients
A New Biologically Active Thymic Protein A to Stimulate Cell–Mediated Immunity
Total Health
Anti-Aging Breakthrough: Thymic Protein A
Indukce apoptózy (buněčné smrti) u aberantních buněk
National Institutes Of Health And UCSD
Induction of Apoptosis by Immune Enhancing Agent In Treatment of Cancer and Viral Infection
Townsend Letter For Doctors And Patients
Pilot Study of the Effects of Thymic Protein on Elevated Epstein-Barr Virus Titers
Searchlight
The FIV Connection – Why Cats May be the Purr-fect Model for HIV Infection
Patenty podle kterých je ProBoost vyráběný
patent US5616554A
Immune-enhancing agent for therapeutic use in immunocompromised hosts
Patent US20070190025A1
Method to enhance hematopoiesis
Patent US7776818B2
Methods to treat T-cell disorders using TISF
Odkazy, články
Induction of T-cell maturation by a cloned line of thymic
epithelium (TEPI)
(interleukin 2 production/cytolytic T-cell activity)
TERRY R. BEARDSLEY*t, MICHAEL PIERSCHBACHERt, GAYLE D. WETZEL*, AND ESTHER F. HAYS
Immunologic Effects of Human Thymic Stromal Grafts and
Cell Lines1
ESTHER F. HAYS* AND TERRY R. BEARDSLEY†
Lymphocyte T-Cell
Immunomodulator (LTCI): Review
of the Immunopharmacology of a
New Veterinary Biologic
Daniel A. Gingerich, DVM, MS
Thymic function in the regulation of T cells, and molecular mechanisms underlying the modulation of cytokines and stress signaling
Pharmacological Inhibition of Feline Immunodeficiency Virus (FIV)
Management Of Feline Chronic Gingivostomatitis of Suspected Viral Origin With A Thymic Extract
Lyme Disease Supports and Treatments. Thymic Protein A
Lymphocyte T-Cell Immunomodulator (LTCI), a Potent Immune Modulating Biologic, Exhibits Safety and Efficacy in the Pain Management of Dogs with Moderate-Severe Osteoarthritis.
Factors affecting immune responsiveness in vitro of germfree allogeneic radiation chimeras. I. Differences between donor and host strains
Gross Murine Leukemia Virus-induced Alterations in the Thymus of Preleukemic AKR Mice
Lymphocytes subsets in osteoarthritis versus rheumatoid arthritis.
Leheita O, Abed Elrazek NY, Younes S, et al. [Journal Article] Egypt J Immunol 2005; 12(2):113-24
Preferential accumulation of activated Th1 cells not only in rheumatoid arthritis but also in osteoarthritis joints
Hisakata Yamada 1, Yasuharu Nakashima, Ken Okazaki, Taro Mawatari, Jun-ichi Fukushi, Akiko Oyamada, Kenjiro Fujimura, Yukihide Iwamoto, Yasunobu Yoshikai
Lymphocyte Populations in Joint Tissues from Dogs with Inflammatory Stifle Arthritis and Associated Degenerative Cranial Cruciate Ligament Rupture
Vyléčení patnácti pacientů se suchou FIP pomocí LCTI
Healing Hearts Animal Rescue
New Research on LTCI
English 
Čeština